Literature DB >> 1672489

Postoperative neuromuscular function in pediatric day-care patients.

M R Baxter1, J C Bevan, J Samuel, F Donati, D R Bevan.   

Abstract

After anesthesia employing nondepolarizing muscle relaxants, 30%-40% of adult patients demonstrate residual paralysis with a train-of-four ratio less than 70%, but it is not known if the same is true for children. This study was designed to investigate neuromuscular transmission in 91 ASA physical status I or II day-care children (aged 0-10 yr) after halothane anesthesia in which pancuronium (n = 34), atracurium (n = 32), or vecuronium (n = 25) was administered. Peripheral nerve stimulation was used clinically to assess neuromuscular blockade during surgery. In the recovery room, the evoked response of the adductor pollicis muscle was measured by train-of-four stimulation of the ulnar nerve. This measurement was made (mean +/- SEM) at 18.0 +/- 1.5, 15.0 +/- 1.3, and 15.0 +/- 1.7 min after pharmacologic antagonism with 0.02 mg/kg atropine and 0.06 mg/kg neostigmine in the pancuronium, atracurium, and vecuronium groups, respectively. There were no differences in the ages of the patients in the three groups at 4.3 +/- 0.4, 4.0 +/- 0.4, and 5.0 +/- 0.5 yr, with 17 children less than 2 yr. Recovery from neuromuscular blockade in all three groups was almost complete. The train-of-four ratio (height of fourth twitch compared with the first) was similar in patients who had received pancuronium (96.7% +/- 0.9%), atracurium (95.5% +/- 0.9%), or vecuronium (96.3% +/- 1.3%). Therefore, postoperative muscle weakness or respiratory impairment is unlikely in pediatric day-care surgical patients more than 2 yr old when these anesthetic techniques are used.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672489     DOI: 10.1213/00000539-199104000-00015

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

1.  Is neuromuscular blocker needed in children undergoing inguinal herniorrhaphy?: A prospective, randomized, and controlled trial.

Authors:  Bon-Wook Koo; Kyu-Whan Jung; Ah-Young Oh; Eun-Young Kim; Hyo-Seok Na; Eun-Su Choi; Kwang-Suk Seo
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

2.  Risk factors for administration of additional reversal following neuromuscular blockade with rocuronium in children: A retrospective case-control study.

Authors:  Susan R Vishneski; Amit K Saha; Madeline R Fram; Leah B Templeton; Lisa K Lee; Douglas G Ririe; Eduardo Javier Goenaga-Diaz; Laura Daniela Smith; Thomas Wesley Templeton
Journal:  Paediatr Anaesth       Date:  2022-05-01       Impact factor: 2.129

3.  The efficacy and safety of sugammadex for reversing postoperative residual neuromuscular blockade in pediatric patients: A systematic review.

Authors:  Guangyu Liu; Rui Wang; Yanhong Yan; Long Fan; Jixiu Xue; Tianlong Wang
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.